Adaptimmune Therapeutics
ADAP
#9421
Rank
C$81.95 M
Marketcap
$0.32
Share price
-12.60%
Change (1 day)
-82.78%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$0.33 Billion

According to Adaptimmune Therapeutics's latest financial reports the company's total liabilities are C$0.33 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Adaptimmune Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.32 B-3.81%
2022-12-31C$0.33 B-0.21%
2021-12-31C$0.33 B139.69%
2020-12-31C$0.14 B85.32%
2019-12-31C$75.62 M85.99%
2018-12-31C$40.66 M-58.62%
2017-12-31C$98.27 M6.95%
2016-12-31C$91.88 M
2015-06-30C$51.69 M-8.73%
2014-06-30C$56.64 M1257.61%
2013-06-30C$4.17 M0.19%
2012-06-30C$4.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$3.10 B 832.99%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.7 M-91.08%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.80 B 140.60%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$1.00 B 200.49%๐Ÿ‡บ๐Ÿ‡ธ USA